Oak Street Health, Inc.
OSHDelisted May 2, 2023- Industry
- Services-Health Services
- SEC CIK
- 0001564406
Oak Street Health, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on May 4, 2023; 273 institutions reported holding it in 13F filings for Q1 2023, worth $8.37B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Oak Street Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Oak Street Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wassong David | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Yadav Ravi | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Newlight Partners LP | Director, 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Newlight GP LLC | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Newlight Harbour Point SPV LLC | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| General Atlantic, L.P. | Director, 10% Owner | 0Indirect | May 2, 2023 | 0 |
| Gap Coinvestments III, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| Gap Coinvestments IV, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| GAP Coinvestments CDA, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic Genpar, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic Partners 93, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic Partners 100, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic (OSH) Interholdco, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic (SPV) GP, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| GAP Coinvestments V, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| Kusserow Paul B. K. | Director | 0 | May 2, 2023 | 0 |
| Dorsey Cheryl | Director | 0 | May 2, 2023 | 0 |
| Klapstein Julie D | Director | 0 | May 2, 2023 | 0 |
| Benjamin Regina M. | Director | 0 | May 2, 2023 | 0 |
| Kaushal Mohit | Director | 0 | May 2, 2023 | 0 |
| Pykosz Michael T | Chief Executive Officer | 0Indirect | May 2, 2023 | 0 |
| Price Geoffrey M | Chief Innovation Officer | 0Indirect | May 2, 2023 | 0 |
| Guenthner Robert | Chief Legal Officer | 0 | May 2, 2023 | 0 |
| Myers Griffin | Chief Medical Officer | 0Indirect | May 2, 2023 | 0 |
| Cook Timothy M | Chief Financial Officer | 0Indirect | May 2, 2023 | 0 |
| Keck Kim | Director | 0 | May 2, 2023 | 0 |
| Clem Brian | Chief Operating Officer | 0 | May 2, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 (view filing) | Feb 23 | 4 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −7.73K | $35.48 | −$274.2K | −0.2%3.87M after | |
| Mar 9, 2023 (view filing) | Mar 7 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $35.54 | −$1.78M | −1.3%3.82M after | |
| Mar 13, 2023 (view filing) | Mar 9 | 4 days | Guenthner RobertChief Legal Officer | SSaleCommon Stock, $0.001 par value | −8.25K | $35.43 | −$292.3K | −1.9%432.8K after | |
| Mar 17, 2023 (view filing) | Mar 15-16 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −81.7K | $35.62 | −$2.91M | −2.1%3.87M after | From original2 lots10b5-1 |
| Mar 21, 2023 (view filing) | Mar 17 | 4 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −37.9K | $35.63 | −$1.35M | −1.0%3.87M after | 10b5-1 |
| Mar 22, 2023 (view filing) | Mar 21 | 1 day | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $35.73 | −$1.79M | −1.3%3.88M after | 10b5-1 |
| Apr 3, 2023 (view filing) | Mar 31 | 3 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −450.0K | $38.69 | −$17.4M | −10.4%3.88M after | 2 lots |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $38.80 | −$1.94M | −1.3%3.88M after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Guenthner RobertChief Legal Officer | SSaleCommon Stock, $0.001 par value | −3.17K | $38.82 | −$123.0K | −0.6%489.3K after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −4.52K | $38.82 | −$175.3K | −0.1%3.88M after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Cook Timothy MChief Financial Officer | SSaleCommon Stock, $0.001 par value | −5.98K | $38.82 | −$232.1K | −0.4%1.46M after | |
| Apr 20, 2023 (view filing) | Apr 18 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $38.88 | −$1.94M | −1.3%3.88M after |